Sector: Pharmaceuticals & Biotechnology

Small Cap

Kilitch DrugsI Share Price

KILITCH

₹179.31

5.10(2.93%)

24th Jul 2026 | 3:28 PM

NSE : KILITCH

Open Free Demat Account

Kilitch DrugsI Performance

Price Movement

₹179.31

₹170.10

₹180.99

↘ Today's Low↗ Today's High

1 Year Performance

₹179.31

₹117.25

₹227.23

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹180.99

Low₹170.10

Open at₹174.21

Prev Close₹174.21

Volumes18.43 K

Avg Price₹177.92

Lower Circuit₹165.50

Upper Circuit₹182.92

Historical Performance

3M High₹207.77

3M Low₹145.50

1 Yr High₹227.22

1 Yr Low₹117.25

3 Yr High₹250.00

3 Yr Low₹85.63

5 Yr High₹250.00

5 Yr Low₹61.16

Summary

As of 27-07-2026 01:18, Kilitch Drugs(I) Ltd. share price today is ₹0, with a change of ₹-174.21 (-100.00%) from the previous close of ₹174.21. The stock opened at ₹174.21 and traded between ₹170.1 and ₹180.99, with a total traded volume of 18428 shares. The company has a market capitalization of ₹609.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹227.23 and ₹117.25, respectively.

Kilitch Drugs(I) Ltd. valuation metrics include a P/E ratio of 20.2, EPS of ₹8.91, and book value of ₹2.20. Profitability indicators show ROE of 10.78%. Kilitch Drugs(I) Ltd. has reported revenue of ₹235.48 Cr and net profit of ₹30.17 Cr.

Kilitch Drugs(I) Ltd. technical indicators include Day RSI at 42.67, Day MFI at 43.73, Day ADX at 22.72. Additional indicators include Commodity Channel Index (CCI) at -110.1 and Williams %R at -76.99. Momentum indicators show Day MACD at -1.24, Day MACD Signal Line at 0.28, DayATR at 8.89. Rate of Change indicators for Kilitch Drugs(I) Ltd. include ROC125 at 3.05 and ROC21 at -9.26.

Exponential moving averages include EMA5 at ₹178.2, EMA10 at ₹180.2, EMA12 at ₹180.8, EMA20 at ₹182.1, EMA26 at ₹182, EMA50 at ₹178.6, EMA100 at ₹173.6, EMA200 at ₹173. Simple moving averages include SMA5 at ₹179, SMA10 at ₹179.7, SMA20 at ₹185, SMA30 at ₹185.4, SMA50 at ₹181.4, SMA100 at ₹165.6, SMA150 at ₹166.7, SMA200 at ₹170.2.

Support levels for Kilitch DrugsI are placed at First Support ₹172.07, Second Support ₹169.94, Third Support ₹166.87. Resistance levels are seen at First Resistance ₹177.27, Second Resistance ₹180.34, Third Resistance ₹182.47. Kilitch Drugs(I) Ltd. shareholding pattern shows promoter holding at 63.77%, FII holding at 0.12%, DII holding at 0%, public holding at 36.11%.

Kilitch DrugsI Fundamentals

Market Cap

Above industry Median

609.10 Cr.

PE Ratio (TTM)

Below industry Median

20.20

Dividend Yield

Net Profit TTM

14.6% incr over last year

30.17

Net Profit Growth

14.6% incr over last year

30.17

PEG Ratio

Above industry Median

1.40

ROE

18% decr over last year

10.78

Operating Revenue TTM

235.48

Operating Revenue Growth

18.7% incr over last year

Book Value

Below industry Median

2.20

MFI

MFI is mid-range

43.73

RSI

RSI is mid-range

42.67

EPS (TTM)

8.91

Debt to Equity

0.32

Face Value

Operating Profit Margin Qtr.

14.83

Operating Profit Qtr.

22.14

Net Profit Qtr.

14.52

Operating Revenue Qtr.

89.60

PB Ratio

2.20

Kilitch DrugsI Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	71.97	44.67	37.81	34.12	56.30
Operating Expense	52.50	38.95	34.14	30.55	42.40
Operating Profit	19.47	5.72	3.67	3.57	13.91
Depreciation	0.70	0.56	0.53	0.50	0.51
Interest	0.58	0.60	0.68	0.59	0.72
Tax	5.33	1.28	1.36	1.19	3.62
Net Profit	14	4.89	8.72	4.79	11.37

Kilitch DrugsI Technicals

Kilitch Drugs(I) Ltd. EMA & SMA

₹179.31

1.13 (0.63%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹178.2

Day EMA10 ₹180.2

Day EMA12 ₹180.8

Day EMA20 ₹182.1

Day EMA26 ₹182

Day EMA50 ₹178.6

Day EMA100 ₹173.6

Day EMA200 ₹173

Kilitch DrugsI Support and Resistance

Resistance

First Resistance₹177.27

Second Resistance₹180.34

Third Resistance₹182.47

Support

First Support₹172.07

Second Support₹169.94

Third Support₹166.87

Technical Indicators

Day RSI42.67

Day MFI43.73

Day ADX22.72

Day Commodity Channel Index-110.10

William-76.99

Day MACD-1.24

Day MACD Signal Line0.28

Day ATR8.89

Day ROC1253.05

Day ROC21-9.26

Kilitch DrugsI Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	69.2	69.2	63.8	63.8	63.8	63.8
FII	0	0	0	0	0	0.1
DII	0	0	0	0	0	0
Public	30.8	30.8	36.2	36.2	36.2	36.1

Kilitch DrugsI Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	17.64 K	17.64 K	100.00%
Week	15.2 K	15.2 K	100.00%
1 Month	40.94 K	66.03 K	61.99%
6 Month	39.2 K	89.48 K	43.81%

Kilitch DrugsI SWOT Analysis

Strengths13

Weakness5

Opportunity1

Threats0

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Companies with 10% increase in share price over three months, with rising net profit growth

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Volume Shockers

Kilitch DrugsI Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
20 Sep, 2019	0.5	FINAL		Equity Share
18 Sep, 2018	0.5	FINAL		Equity Share
24 Sep, 2012	30	SPECIAL	25 Sep, 2012	Equity Share
18 Aug, 2011	1	FINAL		Equity Share
14 Oct, 2010	1	FINAL	15 Oct, 2010	Equity Share
10 Sep, 2009	1	FINAL		Equity Share
10 Sep, 2008	1	FINAL		Equity Share
15 Nov, 2007	1	INTERIM	16 Nov, 2007	Equity Share

Kilitch DrugsI Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹539.10	₹5.25	₹163	₹15.10	₹506	₹61.75
% Change	-0.11%	1.55%	-1.81%	0.13%	-2.65%	-0.82%
Revenue TTM (₹ Cr)	-	₹69.99	₹287.68	₹176.50	₹502.55	₹237.47
Net Profit TTM (₹ Cr)	-	₹-176.47	₹14.88	₹27.81	₹57.92	₹-3.28
PE TTM	-	-0.20	43.30	28.80	25.90	-103.20
1 Year Return	37.68	417	31.75	65.71	-24.97	-35.11
ROCE	3.56	-56.37	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 25.50

-2.00%

WINDLAS

Windlas Biotech Ltd.

₹ 856.00

-0.63%

VINEETLAB

Vineet Laboratories Ltd.

₹ 38.60

+3.21%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 495.00

-5.49%

ZIMLAB

Zim Laboratories Ltd.

₹ 120.40

+1.30%

MEDICO

Medico Remedies Ltd.

₹ 37.93

-0.94%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 183.41

+2.33%

LASA

Lasa Supergenerics Ltd.

₹ 6.97

-1.83%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 317.55

+1.05%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 325.00

+2.30%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.70

-1.41%

BROOKS

Brooks Laboratories Ltd.

₹ 64.40

-2.39%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2970.00

+2.33%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 238.15

-2.00%

ALPA

Alpa Laboratories Ltd.

₹ 66.33

-0.72%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 385.95

+0.34%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.30

-0.58%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.10

-0.26%

INDOCO

Indoco Remedies Ltd.

₹ 243.00

+2.04%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 229.00

+1.33%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 585.00

-0.39%

PANACEABIO

Panacea Biotec Ltd.

₹ 443.00

-0.54%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 243.00

+2.25%

THEMISMED

Themis Medicare Ltd.

₹ 110.64

+2.64%

FAQ's on KILITCH

What is the current share price of Kilitch Drugs(I) Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Kilitch Drugs(I) Ltd. is ₹ 179.31 on the NSE and ₹ 177.2 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Kilitch Drugs(I) Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Kilitch Drugs(I) Ltd. is approximately ₹ 609.1 Cr.

What are the PE and PB ratios for Kilitch Drugs(I) Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Kilitch Drugs(I) Ltd. is 20.2, and the Price-to-Book (PB) ratio is 2.2.

What is the 52-Week High and Low for Kilitch Drugs(I) Ltd.?

Over the past 52 weeks, the highest price reached by Kilitch Drugs(I) Ltd. shares was ₹ 227.22, and the lowest price was ₹ 117.25.

Who are the major shareholders of Kilitch Drugs(I) Ltd.?

Significant shareholdings in Kilitch Drugs(I) Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Kilitch Drugs(I) Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Kilitch Drugs(I) Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Kilitch Drugs(I) Ltd.?

Kilitch Drugs(I) Ltd. last declared a FINAL dividend of ₹ 0.5 per share for the financial period ending 2019. The record date was set as 2019-09-20, and the payment was/is scheduled around 2019-09-20. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy